.ANALYSIS EMPHASIZE.06 August 2024.
A big randomized measured trial along with cisgender females highlights the challenges of adherence to a daily oral preexposure treatment regiment and also shows that twice-yearly shot of lenacapavir may preserve helpful HIV prevention levels over 6 months.